Treatment of excitotoxicity-related conditions

Lars Ittner; Yazi Diana Ke

Treatment of excitotoxicity-related conditions

Lars Ittner (Inventor), Yazi Diana Ke (Inventor)

Research output: Patent

Abstract

Disclosed herein are methods for treating or preventing an excitotoxicity-related condition, optionally a condition associated with seizures and/or resulting from or associated with a cerebral ischemic event, comprising administering to a subject in need an effective amount of an inhibitor of Lim-domain kinase 1 (LIMK1). Also provided are methods for treating or preventing seizures and for reducing excitotoxicity in neurons and/or protecting neurons from excitotoxicity.

Original language	English
Patent number	US2022288081
IPC	A61P 25/ 08 A I,A61K 31/519
Priority date	25/09/19
Filing date	25/09/20
Publication status	Published - 15 Sept 2022

Access to Document

https://patentscope.wipo.int/search/en/detail.jsf?docId=US374019471

3 Patent

Treatment of excitotoxicity-related conditions
Ittner, L. (Inventor) & Ke, Y. D. (Inventor), 3 Aug 2022, IPC No. A61P 25/ 08 A I, A61K 31/519, A61P 25/00, A61K 45/06, A61P 9/10, A61P 27/06, Patent No. EP4034125, Priority date 25 Sept 2019, Priority No. AU2019903588
Research output: Patent

Open Access
Treatment of excitotoxicity-related conditions
Ittner, L. (Inventor) & Ke, Y. D. (Inventor), 19 May 2022, IPC No. A61P 25/ 08 A I, A61K 31/519, A61P 25/00, Patent No. AU2020354786, 25 Sept 2020, Priority date 25 Sept 2020, Priority No. AU2019903588
Research output: Patent

Open Access
Treatment of excitotoxicity-related conditions
Ittner, L. (Inventor) & Ke, Y. D. (Inventor), 1 Apr 2021, IPC No. A61P 25/ 08 A I, A61K 31/519 2006.1, A61P 25/00 2006.1, Patent No. WO2021056072, 25 Sept 2020, Priority date 25 Sept 2019, Priority No. AU20190903588
Research output: Patent

Open Access

Cite this

@misc{c9fe78cafd3e4d1888df3f8a32549f35,

title = "Treatment of excitotoxicity-related conditions",

abstract = "Disclosed herein are methods for treating or preventing an excitotoxicity-related condition, optionally a condition associated with seizures and/or resulting from or associated with a cerebral ischemic event, comprising administering to a subject in need an effective amount of an inhibitor of Lim-domain kinase 1 (LIMK1). Also provided are methods for treating or preventing seizures and for reducing excitotoxicity in neurons and/or protecting neurons from excitotoxicity.",

author = "Lars Ittner and Ke, {Yazi Diana}",

year = "2022",

month = sep,

day = "15",

language = "English",

type = "Patent",

note = "US2022288081; A61P 25/ 08 A I,A61K 31/519",

}

TY - PAT

T1 - Treatment of excitotoxicity-related conditions

AU - Ittner, Lars

AU - Ke, Yazi Diana

PY - 2022/9/15

Y1 - 2022/9/15

N2 - Disclosed herein are methods for treating or preventing an excitotoxicity-related condition, optionally a condition associated with seizures and/or resulting from or associated with a cerebral ischemic event, comprising administering to a subject in need an effective amount of an inhibitor of Lim-domain kinase 1 (LIMK1). Also provided are methods for treating or preventing seizures and for reducing excitotoxicity in neurons and/or protecting neurons from excitotoxicity.

AB - Disclosed herein are methods for treating or preventing an excitotoxicity-related condition, optionally a condition associated with seizures and/or resulting from or associated with a cerebral ischemic event, comprising administering to a subject in need an effective amount of an inhibitor of Lim-domain kinase 1 (LIMK1). Also provided are methods for treating or preventing seizures and for reducing excitotoxicity in neurons and/or protecting neurons from excitotoxicity.

M3 - Patent

M1 - US2022288081

Y2 - 2020/09/25

ER -

Treatment of excitotoxicity-related conditions

Abstract

Access to Document

Fingerprint

Research output